Evidence map›Paper›PMID 9463411›Full record

ArticleThe Journal of experimental medicine1998

Acquisition of Ly49 receptor expression by developing natural killer cells.

J R Dorfman, D H Raulet

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 164 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Functional Characterization of Ly49Frontiers in immunology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Pro-inflammatory role of natural killer cells in the development of allergic airway disease.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2014
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

J R DorfmanDepartment of Molecular and Cell Biology and the Cancer Research Laboratory, University of California at Berkeley, Berkeley, California 94720, USA.
D H Raulet
University of California, Berkeley · US

Funding

EXPRESSION OF CLASS I-SPECIFIC RECEPTORS IN NK CELLSR01AI039642 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI RAULET, DAVID H · 1996 to 2014
$4.9M
NIAID NIH HHS R01 AI039642NIAID NIH HHS R01-AI39642
6 · The paper itself

Abstract

The formation of the repertoire of mouse natural killer (NK) cell receptors for major histocompatibility complex (MHC) class I molecules was investigated by determining the developmental pattern of Ly49 receptor expression. During the first days after birth, few or no splenic NK cells express Ly49A, Ly49C, Ly49G2, or Ly49I receptors. The proportion of Ly49+ splenic NK cells gradually rises to adult levels during the first 6-8 wk of life. The appearance of appreciable numbers of splenic Ly49+ NK cells coincides with the appearance of NK activity at 3-4 wk. After in vivo transfer, NK cells not expressing specific Ly49 receptors can give rise to NK cells that do, and cells expressing one of these four Ly49 receptors can give rise to cells expressing others. Once initiated, expression of a Ly49 receptor is stable for at least 10 d after in vivo transfer. Hence, initiation of Ly49 receptor expression occurs successively. Interestingly, expression of one of the receptors tested, Ly49A, did not occur after in vivo transfer of Ly49A- cells. One possible explanation for these data is that the order of Ly49 receptor expression by NK cells is nonrandom. The results provide a framework for evaluating models of NK cell repertoire formation, and how the repertoire is molded by host class I MHC molecules.

Indexed as

Antigens, LyProteinsAnimalsAntigensAntigens, SurfaceCell DifferentiationCells, CulturedGene Expression Regulation, DevelopmentalKiller Cells, NaturalLectins, C-TypeMembrane GlycoproteinsMiceMice, Inbred C57BLNK Cell Lectin-Like Receptor Subfamily ANK Cell Lectin-Like Receptor Subfamily BProtein BiosynthesisAntigensAntigens, LyAntigens, SurfaceKlra1 protein, mouseKlra3 protein, mouseLectins, C-TypeMembrane GlycoproteinsNK Cell Lectin-Like Receptor Subfamily ANK Cell Lectin-Like Receptor Subfamily BProteinsReceptors, ImmunologicReceptors, NK Cell Lectin-Like

Identifiers

PMID9463411
PMCPMC2212149
OpenAlexW2133655297

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.